| Megan C Daniel, | |
|
700 Childrens Dr, Columbus, OH 43205 | |
| (614) 722-2000 | |
| (614) 722-4565 |
| Full Name | Megan C Daniel |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 13 Years |
| Location | 700 Childrens Dr, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043519812 | NPI | - | NPPES |
| 0098736 | Medicaid | OH |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pediatric Academic Association, Inc. | 2961306774 | 178 |
News Archive
Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.
MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".
For decades, doctors have understood that microbes in the human gut can influence how certain drugs work in the body - by either activating or inactivating specific compounds, but questions have long remained about exactly how the process works.
Non-alcoholic fatty liver disease (NAFLD) is a common affliction, affecting almost 30 percent of Americans, with a significant number suffering from its most severe form, called non-alcoholic steatohepatitis or NASH, which can lead to cirrhosis and liver cancer. In recent years, NASH has become the leading cause of liver transplantation.
A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records, according to a study presented at the 2017 American Thoracic Society International Conference.
› Verified 5 days ago
| Entity Name | Pediatric Academic Association, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063419943 PECOS PAC ID: 2961306774 Enrollment ID: O20031124000198 |
News Archive
Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.
MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".
For decades, doctors have understood that microbes in the human gut can influence how certain drugs work in the body - by either activating or inactivating specific compounds, but questions have long remained about exactly how the process works.
Non-alcoholic fatty liver disease (NAFLD) is a common affliction, affecting almost 30 percent of Americans, with a significant number suffering from its most severe form, called non-alcoholic steatohepatitis or NASH, which can lead to cirrhosis and liver cancer. In recent years, NASH has become the leading cause of liver transplantation.
A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records, according to a study presented at the 2017 American Thoracic Society International Conference.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan C Daniel, 700 Childrens Dr, Columbus, OH 43205-2664 Ph: (614) 722-2000 | Megan C Daniel, 700 Childrens Dr, Columbus, OH 43205 Ph: (614) 722-2000 |
News Archive
Active Implants Corporation (AIC) today announced that it has received a CE Class III Certificate for its TriboFit® Hip System.
MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".
For decades, doctors have understood that microbes in the human gut can influence how certain drugs work in the body - by either activating or inactivating specific compounds, but questions have long remained about exactly how the process works.
Non-alcoholic fatty liver disease (NAFLD) is a common affliction, affecting almost 30 percent of Americans, with a significant number suffering from its most severe form, called non-alcoholic steatohepatitis or NASH, which can lead to cirrhosis and liver cancer. In recent years, NASH has become the leading cause of liver transplantation.
A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records, according to a study presented at the 2017 American Thoracic Society International Conference.
› Verified 5 days ago
Sara Foley Schroder, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2857 W Broad St, Columbus, OH 43204 Phone: 614-722-6200 | |
Mr. Christopher Jones, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-2000 | |
Claire Elizabeth Christian, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-2000 | |
Laura Gardner Hamant, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-2000 | |
Valentina Gutierrez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 80 E Rich St Apt 819, Columbus, OH 43215 Phone: 380-242-1699 | |
Leif Daniel Nelin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-4559 Fax: 614-722-4541 | |
Matthew Joseph Morrison, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1830 Bethel Rd, Suite C, Columbus, OH 43220 Phone: 614-326-1600 Fax: 614-326-3600 |